Prelude Capital Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $11K | Sell |
|
|||||
|
2020
Q2 | $9K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $21K | Sell |
|
|||||
|
2019
Q3 | $59K | Buy |
|
|||||
|
2019
Q2 | $58K | Buy |
|
|||||
|
2019
Q1 | $35K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $37K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $50K | Buy |
|
|||||
|
2014
Q4 | $46K | Sell |
|
|||||
|
2014
Q3 | $187K | Buy |
|
|||||
|
2014
Q2 | $73K | Buy |
|